6,072 results on '"Lipidoses"'
Search Results
2. Liver Adiposity Effects on Pediatric Statin
- Author
-
Jon Wagner, Principal Investigator
- Published
- 2024
3. International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
- Published
- 2024
4. The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT
- Author
-
Bakirkoy Dr. Sadi Konuk Research and Training Hospital and EDA KILINÇ İŞLEYEN, Assistant Profesor Dr.
- Published
- 2024
5. The evolving landscape of ER-LD contact sites.
- Author
-
Kumar, Akhil, Yadav, Surabhi, and Choudhary, Vineet
- Subjects
LIPIDOSES ,ORGANELLE formation ,ENDOPLASMIC reticulum ,FATTY acids ,HOMEOSTASIS - Abstract
Lipid droplets (LDs) are evolutionarily conserved dynamic organelles that play an important role in cellular physiology. Growing evidence suggests that LD biogenesis occurs at discrete endoplasmic reticulum (ER) subdomains demarcated by the lipodystrophy protein, Seipin, lack of which impairs adipogenesis. However, the mechanisms of how these domains are selected is not completely known. These ER sites undergo ordered assembly of proteins and lipids to initiate LD biogenesis and facilitate establishment of ER-LD contact sites, a prerequisite for proper growth and maturation of droplets. LDs retain both physical and functional association with the ER throughout their lifecycle to facilitate bi-directional communication, such as exchange of proteins and lipids between the two organelles at these ER-LD contact sites. In recent years several molecular tethers have been identified that bridge ER and LDs together including few proteins that are found exclusively at these ER-LD contact interface. Here, we discuss recent advances in understanding the role of factors that ensure functionality of ER-LD contact site machinery for LD homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease.
- Author
-
Caifeng Zhang, Keke Su, Xu Jiang, Yuping Tian, and Ke Li
- Subjects
NIEMANN-Pick diseases ,LIPIDOSES ,SMALL molecules ,THERAPEUTICS ,GENE therapy - Abstract
Niemann-Pick disease type C1 (NP-C1) is a rare and devastating recessive inherited lysosomal lipid and cholesterol storage disorder caused by mutations in the NPC1 or NPC2 gene. These two proteins bind to cholesterol and cooperate in endosomal cholesterol transport. Characteristic clinical manifestations of NPC1 include hepatosplenomegaly, progressive neurodegeneration, and ataxia. While the rarity of NP-C1 presents a significant obstacle to progress, researchers have developed numerous potential therapeutic approaches over the past two decades to address this condition. Various methods have been proposed and continuously improved to slow the progression of NP-C1, although they are currently at an animal or clinical experimental stage. This overview of NPC1 therapy will delve into different theoretical treatment strategies, such as small molecule therapies, cell-based approaches, and gene therapy, highlighting the complex therapeutic challenges associated with this disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report.
- Author
-
Yang, Tong, Zhu, Jie, Kang, Yulai, Tang, Chunhua, Zhang, Lili, and Guo, Lu
- Subjects
- *
LIPIDOSES , *LIPID metabolism disorders , *SYMPTOMS , *MUSCULAR atrophy , *DELAYED diagnosis - Abstract
Background: Neutral Lipid Storage Disease with Myopathy (NLSDM) is a rare lipid metabolism disorder caused by PNPLA2 gene mutations. Clinical manifestations are heterogeneous, and diagnosis is often delayed, usually gaining patients' attention due to the increased risk of cardiomyopathy. Case presentation: We herein report a 36-year-old Asian male presenting with progressive limb weakness, muscle atrophy of limbs and trunk, dysarthria, and heart failure. Electromyography indicated myogenic changes, and muscle biopsy results revealed characteristics of lipid storage myopathy. Genetic analysis of PNPLA2 revealed two heterozygous mutations: c.757 + 1G > T (chr11-823588, splice-5) on intron 6 and c.919delG (chr11-823854, p.A307Pfs*13) on exon 7. The patient improved limb strength, and dysarthria disappeared after the Medium Chain Fatty Acids diet. Conclusions: In conclusion, we report for the first time that the two heterozygous mutations PNPLA2 c.919delG and c.757 + 1G > T together induced NLSDM, which was confirmed by muscle biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Dilated cardiomyopathy caused by mutation of the PNPLA2 gene: a case report and literature review.
- Author
-
Shuai Wang, Sha Wu, and Daoquan Peng
- Subjects
LIPIDOSES ,DILATED cardiomyopathy ,LITERATURE reviews ,HYPERTROPHIC cardiomyopathy ,CREATINE kinase - Abstract
Deficiency of adipose triglyceride lipase (ATGL) due to mutation in PNPLA2 causes neutral lipid storage disease with myopathy (NLSDM), an autosomal recessive disorder (MIM: #610717). NLSDM patients are mainly affected by progressive myopathy, cardiomyopathy, and hepatomegaly. Cardiac involvement was reported in 40%-50% of NLSDM patients. Patients with cardiac involvement have adult-onset progressive heart failure, mimicking dilated or hypertrophic cardiomyopathy. The clinical characteristics, genotype-phenotype correlation, and prognosis of cardiomyopathy secondary to PNPLA2 mutation are not understood. We reported two male patients carrying a homozygous splicing mutation NM_020376.4 (c.757 + 1G>T) in PNPLA2, presenting with severe dilated cardiomyopathy and mild skeletal muscle involvement. Through the literature review, the ECG and imaging features and the prognosis of 49 previously reported cases of cardiomyopathy caused by the PNPLA2 mutation were summarized. This study suggests that NLSDM should be considered a cause of cardiomyopathy, especially in those with elevated creatine kinase (CK) levels, regardless of whether symptoms such as muscle weakness or atrophy are present. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Clinicogenetic characterization of cerebrotendinous xanthomatosis in Brazil.
- Author
-
Fussiger, Helena, Lima, Pedro Lucas G. S. B., Souza, Paulo V. S., Freua, Fernando, Husny, Antonette S. E., Leão, Emília K. E. A., Braga‐Neto, Pedro, Kok, Fernando, Lynch, David S., Saute, Jonas A. M., and Nóbrega, Paulo R.
- Subjects
- *
INBORN errors of metabolism , *LIPIDOSES , *LATIN Americans , *GENETIC disorders , *CHENODEOXYCHOLIC acid - Abstract
There are few cerebrotendineous xanthomatosis (CTX) case series and observational studies including a significant number of Latin American patients. We describe a multicenter Brazilian cohort of patients with CTX highlighting their clinical phenotype, recurrent variants and assessing possible genotype–phenotype correlations. We analyzed data from all patients with clinical and molecular or biochemical diagnosis of CTX regularly followed at six genetics reference centers in Brazil between March 2020 and August 2023. We evaluated 38 CTX patients from 26 families, originating from 4 different geographical regions in Brazil. Genetic analysis identified 13 variants in the CYP27A1 gene within our population, including 3 variants that had not been previously described. The most frequent initial symptom of CTX in Brazil was cataract (27%), followed by xanthomas (24%), chronic diarrhea (13.5%), and developmental delay (13.5%). We observed that the median age at loss of ambulation correlates with the age of onset of neurological symptoms, with an average interval of 10 years (interquartile range 6.9 to 11 years). This study represents the largest CTX case series ever reported in South America. We describe phenotypic characteristics and report three new pathogenic or likely pathogenic variants. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia
- Published
- 2024
11. Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency (ASCEND)
- Published
- 2023
12. International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
- Published
- 2023
13. Differently increased volumes of multiple brain areas in Npc1 mutant mice following various drug treatments.
- Author
-
Antipova, Veronica, Heimes, Diana, Seidel, Katharina, Schulz, Jennifer, Schmitt, Oliver, Holzmann, Carsten, Rolfs, Arndt, Bidmon, Hans-Jürgen, de San Román Martín, Estibaliz González, Huesgen, Pitter F., Amunts, Katrin, Keiler, Jonas, Hammer, Niels, Witt, Martin, and Wree, Andreas
- Subjects
LIPIDOSES ,LYSOSOMAL storage diseases ,NIEMANN-Pick diseases ,PURKINJE cells ,EARLY death - Abstract
Background: Niemann-Pick disease type C1 (NPC1, MIM 257220) is a heritable lysosomal storage disease characterized by a progressive neurological degeneration that causes disability and premature death. A murine model of Npc1
-/- displays a rapidly progressing form of Npc1 disease, which is characterized by weight loss, ataxia, and increased cholesterol storage. Npc1-/- mice receiving a combined therapy (COMBI) of miglustat (MIGLU), the neurosteroid allopregnanolone (ALLO) and the cyclic oligosaccharide 2-hydroxypropyl-ß-cyclodextrin (HPßCD) showed prevention of Purkinje cell loss, improved motor function and reduced intracellular lipid storage. Although therapy of Npc1-/- mice with COMBI, MIGLU or HPßCD resulted in the prevention of body weight loss, reduced total brain weight was not positively influenced. Methods: In order to evaluate alterations of different brain areas caused by pharmacotherapy, fresh volumes (volumes calculated from the volumes determined from paraffin embedded brain slices) of various brain structures in sham- and drug-treated wild type and mutant mice were measured using stereological methods. Results: In the wild type mice, the volumes of investigated brain areas were not significantly altered by either therapy. Compared with the respective wild types, fresh volumes of specific brain areas, which were significantly reduced in sham-treated Npc1-/- mice, partly increased after the pharmacotherapies in all treatment strategies; most pronounced differences were found in the CA1 area of the hippocampus and in olfactory structures. Discussion: Volumes of brain areas of Npc1-/- mice were not specifically changed in terms of functionality after administering COMBI, MIGLU, or HPßCD. Measurements of fresh volumes of brain areas in Npc1-/- mice could monitor region-specific changes and response to drug treatment that correlated, in part, with behavioral improvements in this mouse model. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
14. Graduate Student Literature Review: Exploring choline's important roles as a nutrient for transition dairy cows.
- Author
-
Arshad, U. and Santos, J.E.P.
- Subjects
- *
CHOLINE , *LITERATURE reviews , *DAIRY cattle , *CHYLOMICRONS , *GRADUATE students , *ENDOPLASMIC reticulum , *LIPIDOSES - Abstract
In late gestation and in the first weeks postpartum, lipid droplets accumulate in the hepatic tissue resulting in approximately 40% to 50% of the dairy cows developing hepatic lipidosis in the first weeks of lactation. Elevated concentrations of triacylglycerol in the hepatic tissue are associated with increased risk of peripartum diseases and impaired productive performance. Cows with hepatic lipidosis need to dispose the excess of hepatic triacylglycerol, but this is a slow process in the bovine liver and relies on primary mechanisms such as complete oxidation and ketogenesis because of the limited export of triacylglycerols as lipoproteins. Choline is a lipotropic compound because, among other functions, it facilitates the export of lipids from the liver. Supplementing choline as rumen-protected choline (RPC) to diets of feed-restricted dairy cows reduces the degree of triacylglycerol infiltration into the hepatic parenchyma in part by enhancing export of triacylglycerol as nascent lipoprotein. The reduced accumulation of triacylglycerol in hepatic tissue in feed-restricted cows fed RPC might affect secondary pathways involved in hepatic disposal of fatty acids such as increased cellular autophagy and lipophagy and minimize endoplasmic reticulum stress response and hepatocyte inflammation. Collectively, these effects on secondary pathways might further reduce the severity of hepatic lipidosis in cows. One of the benefits of supplementing RPC is improved fat digestibility, perhaps because choline, through phosphatidylcholines, facilitates lipid transport within the enterocyte by increasing the synthesis of chylomicrons. Finally, when supplemented during the transition period, RPC improves productive performance of cows, irrespective of their body condition, that extends well beyond the period of supplementation. This review summarizes the current understanding of hepatic lipidosis in early lactation, recapitulates the absorption, transport and metabolism of choline, and discusses its role on hepatic metabolism and gastrointestinal functions, which collectively results in improved performance in dairy cows. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. The Diagnostic Value of Serum Amyloid A and Other Laboratory and Clinical Variables in Cats with Increased Liver Enzyme Activity.
- Author
-
Öberg, Josefine, Häggström, Jens, Pelander, Lena, Hillström, Anna, and Ljungvall, Ingrid
- Subjects
ACUTE phase proteins ,LIVER enzymes ,CAT diseases ,VETERINARY hospitals ,LIPIDOSES - Abstract
Simple Summary: In this retrospective medical record study, we evaluated if certain diagnostic variables, including Serum Amyloid A (SAA), could differentiate (1) between various clinical disease categories and (2) between cytological findings of severe hepatic lipidosis and other cytological findings in cats diagnosed with increased liver enzymes at a Swedish animal hospital. Grouping into four clinical disease categories (primary liver diseases, trauma, extrahepatic diseases, and other non-specified diagnoses) was based on clinical diagnosis or information from medical records. Serum Amyloid A was found to be higher in the group of cats with diagnoses supporting trauma. Cats with cytological findings supporting severe hepatic lipidosis had lower SAA and were younger, compared to cats with other cytological findings. Distinguishing inflammatory from non-inflammatory liver disease in cats may impact management. The study aim was to evaluate if certain diagnostic variables, including Serum Amyloid A (SAA), differ (1) between various clinical disease categories (Primary liver disease, Extrahepatic, Trauma and Inconclusive) and (2) between cytological findings of severe hepatic lipidosis and other cytological findings in cats with increased liver enzymes. Medical records from 5042 cats, where SAA had been measured, were reviewed, and 566 cats fulfilled inclusion criteria consisting of increased liver enzymes and available biochemical panel results. SAA was higher in cats diagnosed with trauma compared to other diseases (p = 0.008). Cytology results were available in 85 cats, and cats with severe lipidosis had lower serum SAA concentration (p < 0.0001) and were younger (p < 0.0002) compared to cats with other cytological findings. The study shows that SAA was higher in cats diagnosed with trauma compared to cats with other causes of increased liver enzymes and that SAA may be useful to distinguish cats with cytologic evidence of hepatic lipidosis from cats with other liver pathologies. Serum Amyloid A may be a valuable complement to liver cytology when investigating cats with increased liver enzymes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Increased lipogenesis and lipidosis of gallbladder epithelium in dogs with gallbladder mucocele formation.
- Author
-
Gookin, Jody L., Jewell, Dennis E., Aicher, Kathleen M., Seiler, Gabriela S., Cullen, John M., and Mathews, Kyle G.
- Subjects
- *
GALLBLADDER , *MUCUS , *INDUCTIVELY coupled plasma mass spectrometry , *LIPIDOSES , *OMEGA-3 fatty acids , *LIPID synthesis , *DOGS - Abstract
Background: Gallbladder disease in people is frequently associated with disorders of lipid metabolism and metabolic syndrome. A recently emergent gallbladder disease of dogs, referred to as mucocele formation, is characterized by secretion of abnormal mucus by the gallbladder epithelium and is similarly associated with hyperlipidemia, endocrinopathy, and metabolic dysfunction. The cause of gallbladder mucocele formation in dogs is unknown. Methods: A prospective case-controlled study was conducted to gain insight into disease pathogenesis by characterization of plasma lipid abnormalities in 18 dogs with gallbladder mucocele formation and 18 age and breed matched control dogs using direct infusion mass spectrometry for complex plasma lipid analysis. This analysis was complemented by histochemical and ultrastructural examination of gallbladder mucosa from dogs with gallbladder mucocele formation and control dogs for evidence of altered lipid homeostasis of the gallbladder epithelium. Results: Gallbladder mucocele formation in dogs carried a unique lipidomic signature of increased lipogenesis impacting 50% of lipid classes, 36% of esterified fatty acid species, and 11% of complex lipid species. Broad enrichment of complex lipids with palmitoleic acid (16:1) and decreased abundance within complex lipids of presumptive omega-3 fatty acids eicosapentaenoic (20:5) and docosahexaenoic (22:6) was significant. Severe lipidosis of gallbladder epithelium pinpoints the gallbladder as involved causally or consequently in abnormal lipid metabolism. Conclusion: Our study supports a primary increase in lipogenesis in dogs with mucocele formation and abnormal gallbladder lipid metabolism in disease pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. A unifying mechanism for seipin‐mediated lipid droplet formation.
- Author
-
Klug, Yoel A., Ferreira, Joana V., and Carvalho, Pedro
- Subjects
- *
LIPIDOSES , *ORGANELLE formation , *ENDOPLASMIC reticulum , *MEMBRANE proteins , *LIPIDS - Abstract
Lipid droplets (LDs) are dynamic organelles essential for cellular lipid homeostasis. Assembly of LDs occurs in the endoplasmic reticulum (ER), and the conserved ER membrane protein seipin emerged as a key player in this process. Here, we review recent advances provided by structural, biochemical, and in silico analysis that revealed mechanistic insights into the molecular role of the seipin complexes and led to an updated model for LD biogenesis. We further discuss how other ER components cooperate with seipin during LD biogenesis. Understanding the molecular mechanisms underlying seipin‐mediated LD assembly is important to uncover the fundamental aspects of lipid homeostasis and organelle biogenesis and to provide hints on the pathogenesis of lipid storage disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Leukocytes containing lipid inclusions in congenital ichthyosis without classical Chanarin‐Dorfman mutations.
- Author
-
Mallet, Stéphanie, Frankel, Diane, Jonca, Nathalie, Cano, Aline, Roll, Patrice, and Kaspi, Elise
- Subjects
- *
LIPIDOSES , *LEUCOCYTES , *STAINS & staining (Microscopy) , *ERYTHROCYTES , *GROWTH disorders , *ICHTHYOSIS - Abstract
This article describes the case of a female newborn with congenital ichthyosis, a skin disorder characterized by scaling and erythema. The newborn had lipid inclusions in her white blood cells, but did not have the classical mutations associated with Chanarin-Dorfman syndrome (CDS). Instead, genetic analysis revealed mutations in the ALOX12B gene, which is associated with autosomal recessive congenital ichthyosis (ARCI). The case highlights the importance of laboratory analysis and genetic testing in diagnosing and understanding different forms of ichthyosis. Further research is needed to confirm the relationship between ALOX12B mutations and lipid inclusions in leukocytes. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
19. Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population (LB1901)
- Published
- 2023
20. Daily Living Activities and Exercise Capacity in Lipid Storage Diseases
- Author
-
Biruni University and Goksen Kuran Aslan, Associated Proffesor
- Published
- 2023
21. A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)
- Published
- 2023
22. Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy
- Author
-
Barboza, Trinita K, Susta, Leonardo, Zur Linden, Alex, Gardhouse, Sara, and Beaufrère, Hugues
- Subjects
Medical Biochemistry and Metabolomics ,Analytical Chemistry ,Biomedical and Clinical Sciences ,Chemical Sciences ,Digestive Diseases ,Liver Disease ,Clinical Research ,Clinical Trials and Supportive Activities ,Biomedical Imaging ,Animals ,Gemfibrozil ,Succinic Acid ,Ultrasonography ,Liver ,Lipidoses ,Lizards ,General Science & Technology - Abstract
ObjectivesTo evaluate the association between plasma metabolites, biochemical analytes, diagnostic imaging findings, and the histologic diagnosis of hepatic lipidosis in bearded dragons. To assess the effects of gemfibrozil therapy on hepatic lipid accumulation and associated diagnostic tests.AnimalsFourteen bearded dragons (Pogona vitticeps) with varying severity of hepatic lipid accumulation (with and without hepatic lipidosis) were included.ProceduresAnimals underwent coelomic ultrasound, computed tomography (CT) scans, and coelioscopic hepatic biopsies. Clinical pathology tests included lipidologic tests, hepatic biomarkers, and mass spectrometry-based metabolomics. Animals were medicated with gemfibrozil 6mg/kg orally once a day for 2 months in a randomized blinded clinical trial prior to repeating previous diagnostic testing.ResultsHounsfield units on CT were negatively associated with increased hepatic vacuolation, while ultrasound and gross evaluation of the liver were not reliable. Beta-hydroxybutyric-acid (BHBA) concentrations were significantly associated with hepatic lipidosis. Metabolomics and lipidomics data found BHBA and succinic acid to be potential biomarkers for diagnosing hepatic lipidosis in bearded dragons. Succinic acid concentrations were significantly lower in the gemfibrozil treatment group. There was a tendency for improvement in the biomarkers and reduced hepatic fat in bearded dragons with hepatic lipidosis when treated with gemfibrozil, though the improvement was not statistically significant.ConclusionsThese findings provide information on the antemortem assessment of hepatic lipidosis in bearded dragons and paves the way for further research in diagnosis and treatment of this disease.
- Published
- 2023
23. Concept and Diagnostic Challenges of Renal-Limited Hemophagocytic Syndrome/Macrophage Activation Syndrome.
- Author
-
Uchida, Takahiro and Oda, Takashi
- Subjects
- *
HEMOPHAGOCYTIC lymphohistiocytosis , *MACROPHAGE activation syndrome , *MULTIPLE organ failure , *ACUTE kidney failure , *LIPIDOSES , *IMMUNE system - Abstract
Hemophagocytic syndrome/macrophage activation syndrome (HPS/MAS) is a serious clinical condition that frequently leads to multiple organ failure, including acute kidney injury (AKI). Although the pathogenesis of AKI is not yet fully understood, it is believed to result from uncontrolled activation of the immune system involving macrophages and cytotoxic lymphocytes. Renal histology in HPS/MAS often presents with characteristic foamy glomerular lesions (glomerular lipidosis) with massive macrophage infiltration, known as histiocytic glomerulopathy. In this review, we introduce the recently proposed concept of renal-limited HPS/MAS as a novel etiology of histiocytic glomerular lipidosis. Patients with renal-limited HPS/MAS often develop AKI but do not fulfill the diagnostic criteria for HPS/MAS because their systemic manifestations are less severe. Therefore, the diagnosis largely depends on characteristic histological findings, that is, diffuse and global glomerular accumulation of foamy macrophages and cytotoxic lymphocytes accompanied by the interaction of these cells as well as the exclusion of various differential diseases. Although there are no established therapeutic regimens, these patients receive various types of therapies, including high-dose glucocorticoids, immunosuppressants, or anti-interleukin-1 drug, and generally achieve favorable outcomes. We summarized the concept, diagnostic challenges, and recent topics of this disease entity and discussed treatment options based on our own experiences. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Endo-lysosomal dysfunction and neuronal–glial crosstalk in Niemann–Pick type C disease.
- Author
-
Malara, Mariagiovanna, Prestel, Matthias, and Tahirovic, Sabina
- Subjects
- *
LIPIDOSES , *NEURAL stem cells , *AMPA receptors , *HOMEOSTASIS , *GLYCOSPHINGOLIPIDS , *MEMBRANE lipids - Abstract
Niemann–Pick type C (NPC) disease is a rare progressive lysosomal lipid storage disorder that manifests with a heterogeneous spectrum of clinical syndromes, including visceral, neurological and psychiatric symptoms. This monogenetic autosomal recessive disease is largely caused by mutations in the NPC1 gene, which controls intracellular lipid homeostasis. Vesicle-mediated endo-lysosomal lipid trafficking and non-vesicular lipid exchange via inter-organelle membrane contact sites are both regulated by the NPC1 protein. Loss of NPC1 function therefore triggers intracellular accumulation of diverse lipid species, including cholesterol, glycosphingolipids, sphingomyelin and sphingosine. The NPC1-mediated dysfunction of lipid transport has severe consequences for all brain cells, leading to neurodegeneration. Besides the cell-autonomous contribution of neuronal NPC1, aberrant NPC1 signalling in other brain cells is critical for the pathology. We discuss here the importance of endo-lysosomal dysfunction and a tight crosstalk between neurons, oligodendrocytes, astrocytes and microglia in NPC pathology. We strongly believe that a cell-specific rescue may not be sufficient to counteract the severity of the NPC pathology, but targeting common mechanisms, such as endo-lysosomal and lipid trafficking dysfunction, may ameliorate NPC pathology. This article is part of a discussion meeting issue 'Understanding the endo-lysosomal network in neurodegeneration'. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Comparison of serum very low-density lipoprotein concentrations during transition in primiparous and multiparous cows.
- Author
-
Shinya OSADA, Kyoko CHISATO, Rika FUKUMORI, and Shin OIKAWA
- Subjects
COWS ,FATTY acids ,LIPIDOSES ,BLOOD sampling - Abstract
This study was carried out as an observational study in order to examine the difference of change in serum very low-density lipoprotein (VLDL) between primiparous and multiparous cows. Twenty-one clinically healthy cows (10 primiparous and 11 multiparous) were selected at 21 days prior to expected calving. Blood samples were collected in the morning (before feeding) on days -21, -7, 7, 21 and 56 days in milk (DIM). At 7 and 21 DIM, the serum non-esterified fatty acid concentration of multiparous cows was significantly higher than that of primiparous cows. The serum β-hydroxybutyrate concentration was also markedly higher in multiparous cows than in primiparous cows at 21 DIM. These results suggested that the degree of negative energy balance was greater in multiparous cows than in primiparous cows during this period. In both, serum VLDL concentrations decreased at over 7 DIM, increased at 21 DIM, and then decreased at 56 DIM. On the other hand, triglyceride and total protein concentrations of VLDL in multiparous cows were significantly lower than in primiparous cows at 21 DIM. This suggests that multiparous cows have poor triglyceride secretion from the liver and that they become more susceptible to hepatic lipidosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Lipid storage disease in 4 sibling superb birds-of-paradise (Lophorina superba).
- Author
-
McKenzie, Christina M., Marinkovich, Matt, Armién, Aníbal G., Leger, Judy St., Armando, Aaron M., Dennis, Edward A., Quehenberger, Oswald, and Righton, Alison
- Subjects
LIPIDOSES ,PANCREATIC acinar cells ,PARATHYROID glands ,TIME of death ,SIBLINGS ,LIPIDS - Abstract
Pedigree analysis, clinical, gross, microscopic, ultrastructural, and lipidomic findings in 4 female superb bird-of-paradise (SBOP, Lophorina superba) siblings led to the diagnosis of a primary inherited glycerolipid storage disease. These birds were the offspring of a related breeding pair (inbreeding coefficient = 0.1797) and are the only known SBOPs to display this constellation of lesions. The birds ranged from 0.75 to 4.3 years of age at the time of death. Two birds were euthanized and 1 died naturally due to the disease, and 1 died of head trauma with no prior clinical signs. Macroscopic findings included hepatomegaly and pallor (4/4), cardiac and renal pallor (2/4), and coelomic effusion (1/4). Microscopic examination found marked tissue distortion due to cytoplasmic lipid vacuoles in hepatocytes (4/4), cardiomyocytes (4/4), renal tubular epithelial cells (4/4), parathyroid gland principal cells (2/2), exocrine pancreatic cells (3/3), and the glandular cells of the ventriculus and proventriculus (3/3). Ultrastructurally, the lipids were deposited in single to coalescing or fused droplets lined by an inconspicuous or discontinuous monolayer membrane. Lipidomic profiling found that the cytoplasmic lipid deposits were primarily composed of triacylglycerols. Future work, including sequencing of the SBOP genome and genotyping, will be required to definitively determine the underlying genetic mechanism of this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Case report: Preimplantation genetic testing for infantile GM1 gangliosidosis.
- Author
-
Zagaynova, Valeria A., Nasykhova, Yulia A., Tonyan, Ziravard N., Danilova, Maria M., Dvoynova, Natalya M., Lazareva, Tatyana E., Ivashchenko, Tatyana E., Shabanova, Elena S., Krikheli, Inna O., Lesik, Elena A., Bespalova, Olesya N., Kogan, Igor Yu., and Glotov, Andrey S.
- Subjects
GENETIC testing ,RECESSIVE genes ,MICROSATELLITE repeats ,LIPIDOSES ,GENETIC variation ,MUSCLE hypotonia - Abstract
Ganglioside-monosialic acid (GM1) gangliosidosis (ICD-10: E75.1; OMIM: 230500, 230600, 230650) is a rare autosomal recessive hereditary disease, lysosomal storage disorder caused by mutations in the GLB1 gene that lead to the absence or insufficiency of β-galactosidase. In this study, we report a case of a Russian family with a history of GM1 gangliosidosis. The family had a child who, from the age of 6 months, experienced a gradual loss of developmental skills, marked by muscle flaccidity, psychomotor retardation, hepatosplenomegaly, and the onset of tonic seizures by the age of 8 months. Funduscopic examination revealed a «cherry red spot» in the macula, which is crucial for the diagnosis of lipid storage disorders. To find the pathogenic variants responsible for these clinical symptoms, the next-generation sequencing approach was used. The analysis revealed two variants in the heterozygous state: a frameshift variant c.699delG (rs1452318343, ClinVar ID 928700) in exon 6 and a missense variant c.809A>C (rs371546950, ClinVar ID 198727) in exon 8 of the GLB1 gene. The spouses were advised to plan the pregnancy with assisted reproductive technology (ART), followed by preimplantation genetic testing for monogenic disorder (PGT-M) on the embryos. Trophectoderm biopsy was performed on 8 out of 10 resulting embryos at the blastocyst stage. To perform PGT-M, we developed a novel testing system, allowing for direct analysis of disease-causing mutations, as well as haplotype analysis based on the study of polymorphic markers--short tandem repeats (STR), located upstream and downstream of the GLB1 gene. The results showed that four embryos were heterozygous carriers of pathogenic variants in the GLB1 gene (#1, 2, 5, 8). Two embryos had a compound heterozygous genotype (#3, 4), while the embryos #7 and 9 did not carry disease-causing alleles of the GLB1 gene. The embryo #7 without pathogenic variants was transferred after consideration of its morphology and growth rate. Prenatal diagnosis in the first trimester showed the absence of the variants analyzed in the GLB1 gene in the fetus. The pregnancy resulted in the delivery of a female infant who did not inherit the disease-causing variants in the GLB1 gene. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Cerebrotendinous Xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the CYP27A1 gene.
- Author
-
Köroğlu, Muhammed, Karakaplan, Mustafa, Gündüz, Enes, Kesriklioğlu, Betül, Ergen, Emre, Aslantürk, Okan, and Özdemir, Zeynep Maraş
- Subjects
- *
RECESSIVE genes , *LIPIDOSES , *DYSPLASIA , *DELAYED diagnosis , *GENETIC variation , *CONSCIOUSNESS raising , *ACHILLES tendon - Abstract
Background: Cerebrotendinous Xanthomatosis (CTX) is a rare autosomal recessive lipid storage disorder caused by loss of function variants in the CYP27A1 gene which encodes sterol 27-hydroxylase, on chromosome 2q35. Although the symptoms begin commonly in infancy, CTX diagnosis is often delayed. The aim of this study is to review the orthopedic findings of the disease by providing an overview of the clinical features of the disease. It is to raise awareness of this condition for which early diagnosis and treatment are important. Methods: We retrospectively evaluated the clinical, laboratory, radiological, and genetic findings of eight patients from four families who were admitted to our Orthopedics and Traumatology Department between 2017 and 2022 due to bilateral Achilles tendon xanthomas, were found to have high cholestanol and CYP27A1 gene mutations. Results: The mean age of patients was 37, and five of them were male. The mean age at the onset of symptoms was 9.25 years. The mean age of initial diagnosis was 33.75 years. Between symptom onset and clinical diagnosis, an average delay of 24.5 years was observed. All patients had bilateral Achilles tendon xanthoma. Notably, a novel variant (c.670_671delAA) in CYP27A1 gene was identified in three patients who also presented with peripheral neuropathy and bilateral pes cavus. One patient had osteoporosis and four patients had osteopenia. Five patients had a history of bilateral cataracts. Furthermore, three of the patients had early-onset chronic diarrhea and three of the patients had ataxia. Two of the patients had epilepsy and seven of the patients had behavior-personality disorder. All patients had low intelligence, but none of them had cardiac disease. Conclusion: We present the diagnostic process and clinical features which the largest CTX case series ever reported from single orthopedic clinic. We suggest that patients with normal cholesterol levels presenting with xanthoma being genetically analyzed by testing at their serum cholestanol level, and that all siblings of patients diagnosed with CTX be examined. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients.
- Author
-
Shahriyari, Hamed, Ramezani, Mahtab, Nilipour, Yalda, Okhovat, Ali Asghar, Kariminejad, Ariana, Aghaghazvini, Leila, Fatehi, Farzad, and Nafissi, Shahriar
- Subjects
- *
LIPIDOSES , *IRANIANS , *MUSCLE diseases , *NEMALINE myopathy , *MUSCLE weakness , *SYMPTOMS - Abstract
• We described the clinicopathologic profile, muscle MRI, and genetic findings of nine Iranian NLSDM patients. • The unique abnormality based on pathology in NLSDM is JA on PBS. • The most frequently occurring mutation among our patients were c.553T>C and c.613dupC in the PNPLA2 gene. The rare disorder known as Neutral Lipid Storage Disease with Myopathy presents with a variety of clinical manifestations, including myopathy, cardiac dysfunction, and other organ complications. Early diagnosis is crucial due to the increased risk of cardiomyopathy. We describe the clinical, histopathological, muscle imaging, and genetic findings of nine neutral lipid storage myopathy patients. Proximal weakness and asymmetric involvement may suggest lipid storage myopathy. While skeletal muscle weakness was the main manifestation in our patients, one case presented only with hyperCKemia. Additionally, three patients had fertility issues, two suffered from diabetes mellitus, two had cardiomyopathy, and one had a history of hypothyroidism. Muscle histopathology revealed lipid depositions and rimmed vacuoles, prompting peripheral blood smears to detect Jordan Anomalies. All muscle biopsies and peripheral blood smear showed lipid droplets, rimmed vacuoles, and Jordan anomaly. Identifying PNPLA2 gene mutations is important for diagnosing neutral lipid storage myopathy; our cases showed some novel mutations. This study highlights the importance of early diagnosis and comprehensive evaluation in managing neutral lipid storage myopathy cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Npc1 gene mutation abnormally activates the classical Wnt signalling pathway in mouse kidneys and promotes renal fibrosis.
- Author
-
Guan, Lihong, Jia, Zisen, Xu, Keli, Yang, Minlin, Li, Xiaoying, Qiao, Liang, Liu, Yanli, and Lin, Juntang
- Subjects
- *
WNT signal transduction , *RENAL fibrosis , *CELLULAR signal transduction , *GENETIC mutation , *LIPIDOSES , *LYSOSOMAL storage diseases - Abstract
Niemann–Pick disease type C1 (NPC1) is a lysosomal lipid storage disease caused by NPC1 gene mutation. Our previous study found that, compared with wild‐type (Npc1+/+) mice, the renal volume and weight of Npc1 gene mutant (Npc1−/−) mice were significantly reduced. We speculate that Npc1 gene mutations may affect the basic structure of the kidneys of Npc1−/− mice, and thus affect their function. Therefore, we randomly selected postnatal Day 28 (P28) and P56 Npc1+/+ and Npc1−/− mice, and observed the renal structure and pathological changes by haematoxylin–eosin staining. The level of renal fibrosis was detected by immunofluorescence histochemical techniques, and western blotting was used to detect the expression levels of apoptosis‐related proteins and canonical Wnt signalling pathway related proteins. The results showed that compared with Npc1+/+ mice, the kidneys of P28 and P56 Npc1−/− mice underwent apoptosis and fibrosis; furthermore, there were obvious vacuoles in the cytoplasm of renal tubular epithelial cells of P56 Npc1−/− mice, the cell bodies were loose and foam‐like, and the canonical Wnt signalling pathway was abnormally activated. These results showed that Npc1 gene mutation can cause pathological changes in the kidneys of mice. As age increased, vacuoles developed in the cytoplasm of renal tubular epithelial cells, and apoptosis of renal cells, abnormal activation of the Wnt signalling pathway, and promotion of renal fibrosis increased. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Lipid droplets in health and disease.
- Author
-
Bohnert, Maria and Schrul, Bianca
- Subjects
- *
LIPOLYSIS , *LIPASES , *LIPIDS , *BILAYER lipid membranes , *LIPIDOSES - Abstract
This article, titled "Lipid droplets in health and disease," provides an overview of the functions and roles of lipid droplets in both physiological and pathological states. Lipid droplets are organelles found in eukaryotic cells that store neutral lipids and play important roles in lipid biology. The article discusses the architecture of lipid droplets, their formation at the endoplasmic reticulum, and the proteins involved in their biogenesis. It also explores the processes of lipid droplet growth, degradation, and communication with other organelles. The authors highlight recent advancements in understanding lipid droplet functions and their implications in various diseases. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
32. Novel compound heterozygous mutations of the NPC1 gene associated with Niemann-pick disease type C: a case report and review of the literature.
- Author
-
Tao, Chaoxin, Zhao, Min, Zhang, Xiaohui, Hao, Jihong, Huo, Qiuyue, Sun, Jie, Xing, Jiangtao, Zhang, Yuna, Zhao, Jianhong, and Huang, Huaipeng
- Subjects
- *
NIEMANN-Pick diseases , *LITERATURE reviews , *LIPIDOSES , *GENETIC mutation , *GENETIC counseling , *GLYCOGEN storage disease type II - Abstract
Background: Niemann-Pick Disease type C is a fatal autosomal recessive lipid storage disorder caused by NPC1 or NPC2 gene mutations and characterized by progressive, disabling neurological deterioration and hepatosplenomegaly. Herein, we identified a novel compound heterozygous mutations of the NPC1 gene in a Chinese pedigree. Case presentation: This paper describes an 11-year-old boy with aggravated walking instability and slurring of speech who presented as Niemann-Pick Disease type C. He had the maternally inherited c.3452 C > T (p. Ala1151Val) mutation and the paternally inherited c.3557G > A (p. Arg1186His) mutation using next-generation sequencing. The c.3452 C > T (p. Ala1151Val) mutation has not previously been reported. Conclusions: This study predicted that the c.3452 C > T (p. Ala1151Val) mutation is pathogenic. This data enriches the NPC1 gene variation spectrum and provides a basis for familial genetic counseling and prenatal diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Association between biochemical parameters and ultrasonographic measurement for the assessment of hepatic lipidosis in dairy cows.
- Author
-
Elshafey, Besheer G., Elfadadny, Ahmed, Metwally, Samy, Saleh, Asmaa G., Ragab, Rokaia F., Hamada, Rania, Mandour, Ahmed S., Hendawy, Amin Omar, Alkazmi, Luay, Ogaly, Hanan A., and Batiha, Gaber El-Saber
- Subjects
- *
ASPARTATE aminotransferase , *DAIRY cattle , *LIPIDOSES , *FREE fatty acids , *OXIDANT status , *3-Hydroxybutyric acid - Abstract
Hepatic lipidosis (HL) is a serious metabolic disorder that affects transient high-producing dairy cows. However, there are many laboratory methods could help in the assessment of HL in dairy cows, the definite diagnosis of the disease under field conditions remains a challenge because of the non-specificity of clinical parameters. The aim of the study was to investigate the utility of serum biomarkers, and ultrasonography (US) measurement to diagnose HL in dairy cows. Forty Holstein dairy cows underwent physical examination and were divided into three groups: non-HL, mild HL, and severe HL groups based on US findings, and the concentrations of beta-hydroxybutyric acid (BHBA) and nonesterified fatty acids (NEFAs). Ultrasound images showed hyperechoic lesions and increased pixel intensity (PI) values of liver echotexture in the HL groups. A significant increase was observed in mild and severe HL groups in the activity of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), BHBA, NEFAs, malondialdehyde (MDA), and nitric oxide (NO) while the concentrations of triglyceride (TG), glutathione (GSH), and total antioxidant capacity (TAC) were significantly decreased. The classification accuracy was in the interest of NEFAs (cut off 0.62 mmol/L, sensitivity 82.6%, specificity 91.7%, and an AUC of 0.913) and BHBA (cut off 1.35 mmol/L, sensitivity 91.31%, specificity of 86.4%, and an AUC 0.812) as important diagnostic parameters. This study offers new insights into the importance of serum biochemical parameters and oxidative stress biomarkers especially, AST, NEFAs, BHBA, and GSH with the digital values of US images for prompt use of minimally invasive techniques to diagnose HL under farm conditions. Serum metabolites and oxidative stress indices could diagnose hepatic lipidosis in dairy cows NEFA and BHBA concentrations and ultrasound digital values can use as a non-invasive way to the classification of hepatic lipidosis degrees in cows under farm condition. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Glomerular lipidosis as a feature of renal-limited macrophage activation syndrome in a transplanted kidney: a case report.
- Author
-
Sugisaki, Kentaro, Uchida, Takahiro, Iwama, Sachiko, Okihara, Masaaki, Akashi, Isao, Kihara, Yu, Konno, Osamu, Kuroda, Masayuki, Koike, Junki, Iwamoto, Hitoshi, and Oda, Takashi
- Subjects
LIPIDOSES ,FOAM cells ,MACROPHAGE activation syndrome ,KIDNEY diseases ,LIVER enzymes ,KIDNEY transplantation ,HYPERFERRITINEMIA - Abstract
Background: Glomerular lipidosis is a rare histological feature presenting the extensive glomerular accumulation of lipids with or without histiocytic infiltration, which develops under various conditions. Among its various etiologies, macrophage activation syndrome (MAS) is a condition reported to be associated with histiocytic glomerular lipidosis. Here we describe the first case of glomerular lipidosis observed in a renal allograft that histologically mimicked histiocytic glomerulopathy owing to MAS. Case presentation: A 42-year-old man underwent successful living-donor kidney transplantation. However, middle-grade proteinuria and increased serum triglyceride levels indicative of type V hyperlipidemia developed rapidly thereafter. An allograft biopsy performed 6 months after the transplantation showed extensive glomerular infiltration of CD68
+ foam cells (histiocytes) intermingled with many CD3+ T-cells (predominantly CD8+ cells). Furthermore, frequent contact between glomerular T-cells and histiocytes, and the existence of activated CD8+ cells (CD8+ , HLA-DR+ cells) were observed by double immunostaining. There was no clinicopathological data suggesting lipoprotein glomerulopathy or lecithin cholesterol acyltransferase deficiency, both of which are well-known causes of glomerular lipidosis. The histological findings were relatively similar to those of histiocytic glomerulopathy caused by MAS. As systemic manifestations of MAS, such as fever, pancytopenia, coagulation abnormalities, hyperferritinemia, increased liver enzyme levels, hepatosplenomegaly, and lymphadenopathy were minimal, this patient was clinicopathologically diagnosed as having renal-limited MAS. Although optimal treatment strategies for MAS in kidney transplant patients remains unclear, we strengthened lipid-lowering therapy using pemafibrate, without modifying the amount of immunosuppressants. Serum triglyceride levels were normalized with this treatment; however, the patient's extensive proteinuria and renal dysfunction did not improve. Biopsy analysis at 1 year after the transplantation demonstrated the disappearance of glomerular foamy changes, but the number of glomerular infiltrating cells remained similar. Conclusion: To our knowledge, this is the first reported case of glomerular lipidosis in a transplanted kidney. Increased interaction-activation of histiocytes (macrophages) and CD8+ T-cells, the key pathogenic feature of MAS, was observed in the glomeruli of this patient, who did not demonstrate overt systemic manifestations, suggesting a pathological condition of renal-limited MAS. The clinical effects of triglyceride-lowering therapy were limited, suggesting that hypertriglyceridemia was not the cause of but rather may be a consequence of renal-limited MAS. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
35. Rumen-protected choline reduces hepatic lipidosis by increasing hepatic triacylglycerol-rich lipoprotein secretion in dairy cows.
- Author
-
Arshad, U., Husnain, A., Poindexter, M.B., Zimpel, R., Nelson, C.D., and Santos, J.E.P.
- Subjects
- *
CHOLINE , *DAIRY cattle , *LIPIDOSES , *CHOLINE chloride , *SECRETION , *HYDROXYCHOLESTEROLS , *FATTY acid oxidation - Abstract
Objectives were to determine the effects of supplementing rumen-protected choline (RPC) on hepatic composition and secretion of triacylglycerol-rich lipoprotein when cows were subjected to feed restriction to develop fatty liver. It was hypothesized that RPC reduces hepatic triacylglycerol by enhancing secretion of hepatic lipoprotein. Pregnant, nonlactating parous Holstein cows (n = 33) at mean (± standard deviation) 234 ± 2.2 d of gestation were blocked by body condition (3.79 ± 0.49) and assigned to receive 0 g/d (CON), 25.8 g/d choline ion from a RPC product containing 28.8% choline chloride (CC; treatment L25.8), or 25.8 g/d of choline ion from a RPC product containing 60.0% CC (H25.8). Cows were fed for ad libitum intake for the first 5 d and restricted to 41% of the net energy for lactation required for maintenance and pregnancy from d 6 to 13. Intake of metabolizable methionine was maintained at 18 g/d during feed restriction by supplying rumen-protected methionine. Hepatic tissue was sampled on d 6 and 13 and analyzed for triacylglycerol and glycogen, and mRNA expression of hepatic tissue was investigated. On d 14, cows were not fed and received a 10% solution of tyloxapol intravenously at 120 mg/kg of body weight to block hydrolysis of triacylglycerols in very low density lipoprotein (VLDL). Blood was sampled sequentially for 720 min and analyzed for concentration of triacylglycerol and total cholesterol. Lymph was sampled 6 h after tyloxapol infusion, and analyzed for concentrations of fatty acids, β-hydroxybutyrate, glucose, triacylglycerol, and total cholesterol. A sample of serum collected at 720 min after tyloxapol was assayed for the metabolome composition. The area under the curve (AUC) of serum triacylglycerol, VLDL cholesterol, and total cholesterol were calculated. Orthogonal contrasts evaluated the effect of supplementing RPC (CON vs. [1/2 L25.8 + 1/2 H25.8]) and source of RPC (L25.8 vs. H25.8). Least squares means and standard errors of the means are presented in sequence as CON, L25.8, H25.8. During feed restriction, supplementation of RPC reduced hepatic triacylglycerol (9.0 vs. 4.1 vs. 4.5 ± 0.6%) and increased glycogen contents (1.9 vs. 3.5 vs. 4.1 ± 0.2%). Similarly, supplementation of RPC increased the expression of transcripts involved in the synthesis and assembly of lipoproteins (MTTP), cellular autophagy (ATG3), and inflammation (TNFA), and reduced the expression of transcripts associated with mitochondrial oxidation of fatty acids (HADHA , MLYCD) and stabilization of lipid droplets (PLIN2). After infusion of tyloxapol, RPC increased the AUC for serum triacylglycerol (21,741 vs. 32,323 vs. 28,699 ± 3,706 mg/dL × min) and VLDL cholesterol (4,348 vs. 6,465 vs. 5,740 ± 741 mg/dL × min) but tended to reduce the concentrations of triacylglycerol in lymph (16.7 vs. 13.8 vs. 11.9 ± 1.9 mg/dL). Feeding RPC tended to increase the concentrations of 89 metabolites in serum, after adjusting for false discovery, including 3 acylcarnitines, 1 AA-related metabolite, 11 bile acids, 1 ceramide, 6 diacylglycerols, 2 dihydroceramides, 1 glycerophospholipid, and 64 triacylglycerols compared with CON. Feeding 25.8 g/d of choline ion as RPC mediated increased hepatic triacylglycerol secretion to promote lipotropic effects that reduced hepatic lipidosis in dairy cows. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Improvement of Physical and Physiological Parameters Through the Use of a Mobile App
- Author
-
Prof. Dr. Alejandro Martínez-Rodríguez, Assistant Professor
- Published
- 2022
37. Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD)
- Published
- 2022
38. Blocking glycosphingolipid production alters autophagy in osteoclasts and improves myeloma bone disease.
- Author
-
Leng, Houfu, Simon, Anna Katharina, and Horwood, Nicole J.
- Subjects
BONE diseases ,LIPIDOSES ,MULTIPLE myeloma ,BONE marrow cells ,OSTEOCLASTS ,GLYCOCALYX - Abstract
Glycosphingolipids (GSLs) are key constituents of membrane bilayers playing a role in structural integrity, cell signalling in microdomains, endosomes and lysosomes, and cell death pathways. Conversion of ceramide into GSLs is controlled by GCS (glucosylceramide synthase) and inhibitors of this enzyme for the treatment of lipid storage disorders and specific cancers. With a diverse range of functions attributed to GSLs, the ability of the GSC inhibitor, eliglustat, to reduce myeloma bone disease was investigated. In pre-clinical models of multiple myeloma, osteoclast-driven bone loss was reduced by eliglustat in a mechanistically separate manner to zoledronic acid, a bisphosphonate that prevents osteoclast-mediated bone destruction. Autophagic degradation of TNF receptor-associated factor 3 (TRAF3), a key step for osteoclast differentiation, was inhibited by eliglustat as evidenced by TRAF3 lysosomal and cytoplasmic accumulation. By altering GSL composition, eliglustat prevented lysosomal degradation whilst exogenous addition of missing GSLs rescued TRAF3 degradation to restore osteoclast formation in bone marrow cells from myeloma patients. This work highlights the clinical potential of eliglustat as a therapy for myeloma bone disease. Furthermore, using eliglustat as a lysosomal inhibitor in osteoclasts may widen its therapeutic uses to other bone disorders such as bone metastasis, osteoporosis and inflammatory bone loss. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Hydroxychloroquine-Induced Phospholipidosis - A Forgotten Complication of a Common Drug.
- Author
-
Kothapalli, Nagamounika, Padiyar, Shivraj, Nair, Aswin M., Manikuppam, Prathyusha, Matthai, Smitha M., Roy, Sanjeet, Pulimood, Anna, Alexander, Suceena, and Mathew, John
- Subjects
- *
DRUG therapy for rheumatism , *HYDROXYCHLOROQUINE , *BIOPSY , *PROTEINURIA , *DIFFERENTIAL diagnosis , *LIPIDOSES , *ELECTRON microscopy , *KIDNEYS , *SYMPTOMS - Abstract
Hydroxychloroquine (HCQ) has immunomodulatory and immunosuppressive properties and is used in many rheumatological conditions like systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome. It is usually a widely used and well-tolerated DMARD (Disease Modifying Anti Rheumatic Drugs). Its most feared toxicities include retinopathy and, rarely, cardiomyopathy. Among its other reported side effects is drug-induced phospholipidosis. Here, we report two cases of HCQ-induced phospholipidosis based on renal biopsy electron microscopy. HCQ-induced phospholipidosis, although uncommon, must be considered as one of the differentials in a patient with persistent proteinuria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients (ASCEND-Peds)
- Published
- 2022
41. The effective treatment of hepatic lipidosis and lipemia in an ornamental hen: a case report.
- Author
-
Houjaqan, Mahdi Khalilzadeh, Salavati, Ali, Shojaei, Iman, Mousavi, Ali, and Peighambari, Seyed Mostafa
- Subjects
- *
LIPIDOSES , *HENS , *HIGH-fat diet , *DECORATION & ornament , *BLOOD testing - Abstract
This study discusses the significant role of lipids in liver functional disorders, emphasizing their impact on metabolic processes and the evaluation of organism and cell function. Hepatic lipidosis, observed across various species, including birds, results from an imbalance in fatty acid metabolism. The study focuses on a case presentation of a laying hen with severe respiratory symptoms and abdominal distension, diagnosed with hepatic lipidosis due to an inappropriate high-fat diet. Diagnostic methods include clinical examinations, blood tests, radiology, and ultrasonography. Treatment involves atorvastatin, furosemide, and dietary adjustments, resulting in a complete recovery. The discussion highlights the metabolic aspects of hepatic lipidosis in laying hens and the challenges in diagnosing pet birds, suggesting biochemical tests and ultrasonography. Additionally, the article explores the application of atorvastatin in treating hyperlipidemia in birds and emphasizes the importance of maintaining a healthy liver in actively egg-laying birds. Our study and experiences have shown that, alongside chemical compounds, herbal compounds can also be utilized for optimal liver health. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. A retrospective study on the liver toxicity of oral retinoids in Chanarin–Dorfman syndrome.
- Author
-
Valette, C., Jonca, N., Fischer, J., Pernin‐Grandjean, J., Granier Tournier, C., Diociaiuti, A., Neri, I., Dreyfus, I., Furman, M., Giehl, K., Wollenberg, A., Mallet, S., Martin, L., Martin‐Santiago, A., Onnis, G., Broue, P., Leclerc‐Mercier, S., Schmuth, M., Sprecher, E., and Gruber, R.
- Subjects
- *
HEPATOTOXICOLOGY , *ICHTHYOSIS , *RETINOIDS , *LIPIDOSES , *HEPATIC fibrosis - Abstract
Patient (F5-1) had a cirrhosis at the age of 34 years (after 12 years of OR), but liver blood parameters remained stable during the 31 years of follow-up. Before introducing OR, all also had liver anomalies, that consisted in either increased liver enzymes, hyper echogenic liver, hepatosplenomaly or cirrhosis for one patient (F6-1). In conclusion, awaiting future targeted therapy for DCS or prospective monitoring studies, there is no safety signal to contraindicate OR in CDS patients with disabling skin anomalies, on condition that a close monitoring is performed. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
43. MicroRNA Profile, Putative Diagnostic Biomarkers and RNA-Based Therapies in the Inherited Lipid Storage Disease Niemann-Pick Type C.
- Author
-
Encarnação, Marisa, David, Hugo, Coutinho, Maria Francisca, Moreira, Luciana, and Alves, Sandra
- Subjects
LIPIDOSES ,NIEMANN-Pick diseases ,NON-coding RNA ,MICRORNA ,LYSOSOMAL storage diseases ,GLYCOGEN storage disease type II - Abstract
Lipids are essential for cellular function and are tightly controlled at the transcriptional and post-transcriptional levels. Dysregulation of these pathways is associated with vascular diseases, diabetes, cancer, and several inherited metabolic disorders. MicroRNAs (miRNAs), in particular, are a family of post-transcriptional gene repressors associated with the regulation of many genes that encode proteins involved in multiple lipid metabolism pathways, thereby influencing their homeostasis. Thus, this class of non-coding RNAs (ncRNAs) has emerged as a promising therapeutic target for the treatment of lipid-related metabolic alterations. Most of these miRNAs act at an intracellular level, but in the past few years, a role for miRNAs as intercellular signaling molecules has also been uncovered since they can be transported in bodily fluids and used as potential biomarkers of lipid metabolic alterations. In this review, we point out the current knowledge on the miRNA signature in a lysosomal storage disorder associated with lipid dysfunction, Niemann-Pick type C, and discuss the potential use of miRNAs as biomarkers and therapeutic targets for RNA-based therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Cerebrotendinous xanthomatosis tremor successfully controlled post-ventral intermediate nucleus-deep brain stimulation: a case report.
- Author
-
Rich, Alyson M., Karakoleva, Ema V., McInerney, James, Farace, Elana, and De Jesus, Sol
- Subjects
BRAIN stimulation ,TREMOR ,DEEP brain stimulation ,ESSENTIAL tremor ,LIPIDOSES ,TREATMENT delay (Medicine) ,DELAYED diagnosis - Abstract
Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive disorder caused by a deficiency of the sterol 27-hydroxylase enzyme. This deficiency results in excess production and accumulation of cholestanol, which can lead to many clinical findings within the first three decades of life, including progressive neurological dysfunction. This is a treatable condition with improvements in neurological and non-neurological symptoms upon the early initiation of replacement therapy. This case report details a 42 years-old left-handed male in whom deep brain stimulation (DBS) intervention was pursued due to a limiting tremor related to delayed diagnosis and treatment of CTX at 22 years old. The application of DBS in treating tremors in a CTX patient has not previously been reported. For our patient, application of DBS led to meaningful and longstanding tremor control benefits that have required minimal changes to stimulation parameters post-DBS. These improvements to tremor were achieved without negative impact to his other CTX related comorbidities. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. HyperCKemia: An early sign of childhood-onset neutral lipid storage disease with myopathy.
- Author
-
Fu, Xiaona, Yang, Xinying, Wang, Xiaofei, Jia, Bingbing, Ma, Wenna, Xiong, Hui, Fang, Fang, Ren, Xiaotun, and Lv, Junlan
- Subjects
- *
LIPIDOSES , *NEUROMUSCULAR diseases , *MUSCLE weakness , *CREATINE kinase , *MUSCLE diseases , *JUVENILE diseases - Abstract
• Creatine kinase levels were moderately to severely elevated in childhood with NLSDM. • Almost half of the patients with NLSDM had cardiac involvement after disease onset. • Hearing loss was more frequent in patients with childhood-onset NLSDM. • All cases of NLSDM presented with Jordans' anomaly. Jordans' anomaly, a rapid examination, can assist in the diagnosis of patients with PNPLA2 variants. Neutral lipid-storage disease with myopathy (NLSDM) is an autosomal recessive neuromuscular disorder caused by mutations in PNPLA2 , and the average age at onset is 30 years. To date, only eight patients with childhood-onset NLSDM have been reported in detail. We investigated 3 unreported patients with NLSDM detected in childhood and reviewed 8 childhood-onset and 82 adult-onset patients with NLSDM documented in the literature. In the childhood-onset cohort, NLSDM presented initially as asymptomatic or paucisymptomatic hyperCKemia in 6/11 patients, and follow-up data showed onset of muscle weakness in 6/11 childhood-onset patients. In the adult-onset cohort, 95.1% (78/82) of patients showed muscle weakness. Cardiac involvement developed in 6/11 childhood-onset patients. Hepatomegaly was observed in 3/11 childhood-onset patients. Serum creatine kinase levels were elevated greater than five-fold of the upper limit of normal (ULN) in most childhood-onset patients and were elevated to less than ten-fold of the ULN in most adult-onset patients. Peripheral blood smears and muscle biopsies showed cytoplasmic lipid droplets in leukocytes and myocytes. NLSDM can present in children with asymptomatic or paucisymptomatic hyperCKemia before the onset of muscle weakness. The presence of lipid droplets in leucocytes (Jordans' anomaly) aids in diagnosing and confirming the pathogenicity of PNPLA2 variants of uncertain significance. There were no clear genotype-phenotype correlations in patients with NLSDM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism.
- Author
-
Jersin, Regine Å., Tallapragada, Divya Sri Priyanka, Skartveit, Linn, Bjune, Mona S., Muniandy, Maheswary, Lee-Ødegård, Sindre, Heinonen, Sini, Alvarez, Marcus, Birkeland, Kåre Inge, Drevon, Christian André, Pajukanta, Päivi, McCann, Adrian, Pietiläinen, Kirsi H., Claussnitzer, Melina, Mellgren, Gunnar, and Dankel, Simon N.
- Subjects
FAT cells ,LIPIDOSES ,INSULIN resistance - Abstract
Context: The neutral amino acid transporter SLC7A10/ASC-1 is an adipocyte-expressed gene with reduced expression in insulin resistance and obesity. Inhibition of SLC7A10 in adipocytes was shown to increase lipid accumulation despite decreasing insulin-stimulated uptake of glucose, a key substrate for de novo lipogenesis. These data imply that alternative lipogenic substrates to glucose fuel continued lipid accumulation during insulin resistance in obesity. Objective: We examined whether increased lipid accumulation during insulin resistance in adipocytes may involve alter flux of lipogenic amino acids dependent on SLC7A10 expression and activity, and whether this is reflected by extracellular and circulating concentrations of marker metabolites. Methods: In adipocyte cultures with impaired SLC7A10, we performed RNA sequencing and relevant functional assays. By targeted metabolite analyses (GC-MS/MS), flux of all amino acids and selected metabolites were measured in human and mouse adipose cultures. Additionally, SLC7A10 mRNA levels in human subcutaneous adipose tissue (SAT) were correlated to candidate metabolites and adiposity phenotypes in 2 independent cohorts. Results: SLC7A10 impairment altered expression of genes related to metabolic processes, including branched-chain amino acid (BCAA) catabolism, lipogenesis, and glyceroneogenesis. In 3T3-L1 adipocytes, SLC7A10 inhibition increased fatty acid uptake and cellular content of glycerol and cholesterol. SLC7A10 impairment in SAT cultures altered uptake of aspartate and glutamate, and increased net uptake of BCAAs, while increasing the net release of the valine catabolite 3- hydroxyisobutyrate (3-HIB). In human cohorts, SLC7A10 mRNA correlated inversely with total fat mass, circulating triacylglycerols, BCAAs, and 3-HIB. Conclusion: Reduced SLC7A10 activity strongly affects flux of BCAAs in adipocytes, which may fuel continued lipogenesis during insulin resistance, and be reflected in increased circulating levels of the valine-derived catabolite 3-HIB. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. SCA34 caused by ELOVL4 L168F mutation is a lysosomal lipid storage disease sharing pathology features with neuronal ceroid lipofuscinosis and peroxisomal disorders.
- Author
-
Ellezam, Benjamin, Kaseka, Matsanga L., Nguyen, Dang Khoa, and Michaud, Jean
- Subjects
- *
LIPIDOSES , *LYSOSOMAL storage diseases , *NEURONAL ceroid-lipofuscinosis , *PEROXISOMAL disorders , *PATHOLOGY , *LIPIDS , *FERRITIN - Abstract
Spinocerebellar ataxia 34 (SCA34) is a late-onset progressive ataxia caused by a mutation in ELOVL4, a gene involved in the biosynthesis of very long-chain fatty acids (VLCFAs). We performed post-mortem neuropathological examinations on four SCA34 patients with the ELOVL4 L168F mutation and compared the findings to age-matched controls. Specific gross findings of SCA34 were limited to pontocerebellar atrophy. On light microscopy, pontine base showed neuronal loss and storage of an autofluorescent lipopigment positive on oil red O, PAS and Hale's colloidal iron and negative on Alcian blue and Luxol fast blue (LFB). Among the swollen neurons were abundant CD68+ /CD163+ /IBA1- macrophages laden with a material with similar histochemical profile as in neurons except for the lack of autofluorescence and oil red O positivity and the presence of needle-like birefringent inclusions. Normal resting IBA1 + microglia were generally absent from pontine base nuclei but present in normal numbers elsewhere in the pons. In dentate nucleus neurons, atrophy was milder than in the pontine base and the coarser storage material was LFB-positive, closely resembling lipofuscin. On electron microscopy, dentate nucleus neurons showed neuronal storage of tridimensionally organized trilaminar spicules within otherwise normal lipofuscin, while in the more affected pontine base neurons, lipofuscin was almost completely replaced by the storage material. Storage macrophages were tightly packed with stacks of unorganized trilaminar spicules, reminiscent of the storage material seen in peroxisomal disorders and thought to represent VLCFAs incorporated in complex polar lipids. In summary, we provide histochemical and ultrastructural evidence that SCA34 is a lipid storage disease, the first among the currently known SCAs, and that the storage lipid is accumulating within neuronal lipofuscin. Our findings suggest that the storage lipid is similar to the one accumulating in non-neuronal cells in peroxisomal disorders and provide the first ultrastructural description of this type of material within neurons. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
- Author
-
Tummino, Tia A, Rezelj, Veronica V, Fischer, Benoit, Fischer, Audrey, O'Meara, Matthew J, Monel, Blandine, Vallet, Thomas, White, Kris M, Zhang, Ziyang, Alon, Assaf, Schadt, Heiko, O'Donnell, Henry R, Lyu, Jiankun, Rosales, Romel, McGovern, Briana L, Rathnasinghe, Raveen, Jangra, Sonia, Schotsaert, Michael, Galarneau, Jean-René, Krogan, Nevan J, Urban, Laszlo, Shokat, Kevan M, Kruse, Andrew C, García-Sastre, Adolfo, Schwartz, Olivier, Moretti, Francesca, Vignuzzi, Marco, Pognan, Francois, and Shoichet, Brian K
- Subjects
Lung ,Infectious Diseases ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Good Health and Well Being ,A549 Cells ,Animals ,Antiviral Agents ,COVID-19 ,Cations ,Chlorocebus aethiops ,Dose-Response Relationship ,Drug ,Drug Repositioning ,Female ,Humans ,Lipidoses ,Mice ,Microbial Sensitivity Tests ,Phospholipids ,SARS-CoV-2 ,Surface-Active Agents ,Vero Cells ,Virus Replication ,COVID-19 Drug Treatment ,General Science & Technology - Abstract
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning with sigma receptor ligands and expanding to other drugs from screening in the field, we became concerned that phospholipidosis was a shared mechanism underlying the antiviral activity of many repurposed drugs. For all of the 23 cationic amphiphilic drugs we tested, including hydroxychloroquine, azithromycin, amiodarone, and four others already in clinical trials, phospholipidosis was monotonically correlated with antiviral efficacy. Conversely, drugs active against the same targets that did not induce phospholipidosis were not antiviral. Phospholipidosis depends on the physicochemical properties of drugs and does not reflect specific target-based activities-rather, it may be considered a toxic confound in early drug discovery. Early detection of phospholipidosis could eliminate these artifacts, enabling a focus on molecules with therapeutic potential.
- Published
- 2021
49. Acarbose has sex-dependent and independent effects on age-related physical function, cardiac health and lipid biology
- Author
-
Herrera, Jonathan J, Louzon, Sean, Pifer, Kaitlyn, Leander, Danielle, Merrihew, Gennifer E, Park, Jea H, Szczesniak, Kate, Whitson, Jeremy A, Wilkinson, John E, Fiehn, Oliver, MacCoss, Michael J, Day, Sharlene M, Miller, Richard A, and Garratt, Michael
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Heart Disease ,Prevention ,Aging ,Cardiovascular ,Liver Disease ,Digestive Diseases ,Good Health and Well Being ,Acarbose ,Age Factors ,Animals ,Cardiomegaly ,Female ,Glycoside Hydrolase Inhibitors ,Heart ,Lipidoses ,Liver Diseases ,Male ,Mice ,Mice ,Inbred BALB C ,Mice ,Inbred C3H ,Mice ,Inbred C57BL ,Physical Conditioning ,Animal ,Sex Factors ,Cellular senescence ,Biomedical and clinical sciences ,Health sciences - Abstract
With an expanding aging population burdened with comorbidities, there is considerable interest in treatments that optimize health in later life. Acarbose (ACA), a drug used clinically to treat type 2 diabetes mellitus (T2DM), can extend mouse life span with greater effect in males than in females. Using a genetically heterogeneous mouse model, we tested the ability of ACA to ameliorate functional, pathological, and biochemical changes that occur during aging, and we determined which of the effects of age and drug were sex dependent. In both sexes, ACA prevented age-dependent loss of body mass, in addition to improving balance/coordination on an accelerating rotarod, rotarod endurance, and grip strength test. Age-related cardiac hypertrophy was seen only in male mice, and this male-specific aging effect was attenuated by ACA. ACA-sensitive cardiac changes were associated with reduced activation of cardiac growth-promoting pathways and increased abundance of peroxisomal proteins involved in lipid metabolism. ACA further ameliorated age-associated changes in cardiac lipid species, particularly lysophospholipids - changes that have previously been associated with aging, cardiac dysfunction, and cardiovascular disease in humans. In the liver, ACA had pronounced effects on lipid handling in both sexes, reducing hepatic lipidosis during aging and shifting the liver lipidome in adulthood, particularly favoring reduced triglyceride (TAG) accumulation. Our results demonstrate that ACA, already in clinical use for T2DM, has broad-ranging antiaging effects in multiple tissues, and it may have the potential to increase physical function and alter lipid biology to preserve or improve health at older ages.
- Published
- 2020
50. Collodion Baby: Answers Beneath the Parchment.
- Author
-
Biswas, Shreshthangsha Sayan and Mathews, Irene
- Subjects
- *
ICHTHYOSIS , *PARCHMENT , *NEONATAL sepsis , *GAUCHER'S disease , *INFANTS , *LIPIDOSES , *INBORN errors of metabolism - Abstract
The article "Collodion Baby: Answers Beneath the Parchment" explores the condition known as collodion baby, which is characterized by a shiny yellow membrane covering the newborn at birth. This membrane eventually sheds, revealing an underlying form of inherited ichthyosis. The severity of the subsequent ichthyosis cannot be predicted initially, and it can lead to various complications such as impaired skin barrier function, bacterial sepsis, and respiratory issues. The article discusses the diagnosis, management, and treatment of collodion baby, emphasizing the importance of maintaining body temperature, preventing dehydration, and monitoring vital signs and blood counts. It also provides information on specific genetic causes and clinical findings that can aid in diagnosing collodion babies. Milder cases and later stages can be managed on an outpatient basis as long as temperature, hydration, and asepsis are maintained. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.